Immunity for the drug industry still exists in Michigan, but that may change

Wyeth decision seen as not enough to end Michigan’s pharmaceutical law. Henry Greenspan, who teaches about the FDA, ethics and policy at the University of Michigan, writes in an op-ed, “Today was a good one for justice in America – but we in Michigan remain saddled with a law that is based on precisely the argument the high court rejected.” He states that the court’s decision in Wyeth “is not enough to end Michigan’s statute.” Greenspan concludes, “The state senators who have blocked repeal will now have to argue that they know better than two-thirds of the Supreme Court” and “they will have to explain why they maintain a view of the FDA that the court called ‘meritless’ and ‘untenable.’” Detroit Free Press (3/5)